Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Percutaneous coronary intervention (PCI) with paclitaxel-eluting stent (TAXUS Element) implantation
DEVICE
2 trials
Sponsors
Boston Scientific Corporation
Conditions
Coronary Artery Disease
Phase 3
TAXUS PERSEUS Workhorse
Completed
NCT00484315
Boston Scientific Corporation
Coronary Artery Disease
Start: 2007-07-31
End: 2013-10-31
Updated: 2014-05-08
TAXUS PERSEUS Small Vessel
Completed
NCT00489541
Boston Scientific Corporation
Coronary Artery Disease
Start: 2007-07-31
End: 2013-10-31
Updated: 2014-05-08
Related Papers
Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trial.
2010-05-20
42 citations
A prospective evaluation of the safety and efficacy of the TAXUS Element paclitaxel-eluting coronary stent system for the treatment of de novo coronary artery lesions: design and statistical methods of the PERSEUS clinical program.
2010-01-07
35 citations